11/06/2024
3:27 PM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
6:40 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
8:02 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:20 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:10 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
3:26 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
5:55 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
11:15 PM | Prelude Therapeutics (Filer)
| Form EFFECT | |
05/08/2024
11:15 PM | Prelude Therapeutics (Filer)
| Form EFFECT | |
05/07/2024
6:12 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:20 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:24 PM | Prelude Therapeutics (Filer)
| Form S-3/A | |
04/26/2024
3:21 PM | Prelude Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:19 PM | Prelude Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:05 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
4:22 PM | Prelude Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
3:22 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
12:34 PM | Prelude Therapeutics (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:30 PM | Flynn James E (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
3:26 PM | Prelude Therapeutics (Subject)
Vaddi Krishna (Filed by)
| Form SC 13G/A | |
01/10/2024
7:53 AM | FMR LLC (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
4:00 PM | Huang Jane (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:35 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:17 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PRLD Stock Alerts